Nanoform is an innovative nanoparticle medicine enabling company. Nanoform works together with pharma and biotech partners globally to provide hope for patients in developing new and improved medicines utilizing Nanoform’s platform technologies. The Company focuses on reducing attrition in clinical trials and on enhancing drug molecules’ formulation performance through its nanoforming services. Nanoform’s capabilities span the small to large molecule development space and the company focuses on solving key issues in drug solubility and bioavailability and on enabling novel drug delivery applications.


Viewers will learn how award-winning CESS® nanoparticle engineering technology can potentially double the number of drug candidates progressing into clinic. The use of this unique process to open up new drug delivery routes and improve the lives of patients worldwide will also be explored.

Christian Jones from Nanoform talks to the DDF Summit in Berlin, Germany, on how the company's award-winning CESS® technology can be used in Nanoforming™ Future Medicines.

The low hanging fruit of drug development – simple compounds – have mainly been used up, prompting companies to focus on more complex molecules. However, the vast majority of these exhibit solubility and bioavailability challenges - but nanoparticles below 100 nm could help.